Michael J. Mann
20Patents
8h-index
23Co-inventors
75Inventor score
Filing activity: Sep 21, 1992 → Dec 5, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5922687A | Intracellular delivery of nucleic acids using pressure | Chemistry; Metallurgy | 72 | Expired |
| US6077256A | Delivery of a composition to the lung | Human Necessities | 41 | Expired |
| US5285112A | Fluid energy collection system | Emerging Cross-Sectional Technologies | 34 | Expired |
| US6722370B1 | Delivery of a composition to the liver by utilizing the portal vein | Human Necessities | 29 | Expired |
| US6199554A | Method and apparatus for combining injury-mediated therapy and drug delivery | Human Necessities | 28 | Expired |
| US6352555B1 | Methods for implanting cells | Emerging Cross-Sectional Technologies | 21 | Expired |
| USD832713S1 | Milk bottle | General | 13 | Active |
| US6926465B1 | Remediation system | Performing Operations; Transporting | 9 | Expired |
| US7013930B2 | Electrostatic dissipation | Performing Operations; Transporting | 8 | Expired |
| US8955279B1 | Resilient cantilevered athletic flooring system | Fixed Constructions | 6 | Active |
| US6579313B2 | Methods for implanting cells | Emerging Cross-Sectional Technologies | 4 | Expired |
| USD598691S1 | Resilient flooring pad | General | 4 | Expired |
| US5766901A | Apparatus and method for delivering a nucleotide into cell nuclei | Chemistry; Metallurgy | 3 | Expired |
| US9370521B2 | Targeting GLI proteins in human cancer by small molecules | Chemistry; Metallurgy | 2 | Active |
| US9840470B2 | Targeting GLI proteins in human cancer by small molecules | Chemistry; Metallurgy | 2 | Active |
| US11560356B2 | Compounds and compositions for the treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US6395550B1 | Method and apparatus for tissue treatment | Human Necessities | 1 | Expired |
| US6294384A | Compositions and methods based upon an isoform of p53 | Human Necessities | 1 | Expired |
| US9476098B2 | Multigene prognostic assay for lung cancer | Physics | 1 | Active |
| US12227482B2 | Compounds and compositions for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.